Evidence map›Paper›PMID 16801422›Full record

ArticleAntimicrobial agents and chemotherapy2006

Mechanism of drug resistance in clonally related clinical isolates of Vibrio fluvialis isolated in Kolkata, India.

Vijaya Bharathi Srinivasan, Rupinder Kaur Virk, Amita Kaundal, Rupa Chakraborty, Basabjit Datta, T Ramamurthy, Asish K Mukhopadhyay, Amit Ghosh

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.6field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. The first report ofIranian journal of microbiology · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Vibrio Pathogens: A Public Health Concern in Rural Water Resources in Sub-Saharan Africa.International journal of environmental research and public health · 2017
    Review
  10. Article
  11. Article
  12. Article
  13. Vibrio fluvialis: an emerging human pathogen.Frontiers in microbiology · 2014
    Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Vijaya Bharathi SrinivasanInstitute of Microbial Technology, Molecular Biology Division, Sector 39A, Chandigarh 160036, India. vijaya@imtech.res.in
Rupinder Kaur Virk
Amita Kaundal
Rupa Chakraborty
Basabjit Datta
T Ramamurthy
Asish K Mukhopadhyay
Amit Ghosh
Institute of Microbial Technology · INNational Institute of Cholera and Enteric Diseases · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The molecular mechanisms of drug resistance in 19 strains of Vibrio fluvialis isolated from 1998 to 2002 in Kolkata, India, were investigated. Class 1 integrons were detected in eight strains, and four strains were found to carry SXT integrases. In the presence of carbonyl cyanide m-chlorophenylhydrazone or reserpine, all nalidixic acid- and ciprofloxacin-resistant strains became sensitive, suggesting that drug efflux plays a major role in quinolone resistance in V. fluvialis. It was further seen that strains which had MICs of > 25 microg/ml for nalidixic acid had a sense mutation (Ser to Ile) at position 83 of the quinolone resistance-determining region of gyrA. All except one of the integron- and SXT integrase-bearing strains belonged to the same ribotype.

Indexed as

Drug Resistance, BacterialAnti-Bacterial AgentsDNA GyraseHospitalizationHumansIndiaIntegrasesIntegronsMicrobial Sensitivity TestsMutationNalidixic AcidPlasmidsQuinolonesVibrioVibrio InfectionsAnti-Bacterial AgentsDNA GyraseIntegrasesNalidixic AcidQuinolones

Identifiers

PMID16801422
PMCPMC1489780
OpenAlexW2100418318

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.